Found 88 matching trials
A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder PHASE3 Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Show More Location
Multiple Locations
Learn More & Join Trial
InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics N/A International Observational Registry on Schizophrenia...
Location
Multiple Locations
Learn More & Join Trial
Comparative Bioavailability of Risperidone PHASE1 This is an open-label, one sequence study to evaluate the steady-state comp...
Show More Location
Collaborative Neuroscience Network
Learn More & Join Trial
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis PHASE4 SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Show More Location
Multiple Locations
Learn More & Join Trial
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants PHASE1 The purpose of this study is to gather information about the steady-state p...
Show More Location
Multiple Locations
Learn More & Join Trial
Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia PHASE4 The purpose of this study is to evaluate efficacy, safety and tolerance of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia PHASE4 This study will determine the effectiveness of oral risperidone versus long...
Show More Location
Semel Institute for Neuroscience and Human Behavior at UCLA
Learn More & Join Trial
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia PHASE3 The purpose of the study is to compare the effectiveness and safety of a lo...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia PHASE3 In the proposed study 450 veterans with a primary diagnosis of schizophreni...
Show More Location
VA Medical Center, Tuscaloosa
Learn More & Join Trial
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis PHASE4 The purpose of this study is to evaluate the effectiveness, safety and tole...
Show More Location
Multiple Locations
Learn More & Join Trial